# Special Edition: Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Page: https://stenobird.com/podcast/doc-updates-200053/special-edition-metabolic-dysfunction-associated-steatotic-liver-disease-masld-and-metabolic-dysfunction-associated-steatohepatitis-mash
Text version: https://stenobird.com/podcast/doc-updates-200053/special-edition-metabolic-dysfunction-associated-steatotic-liver-disease-masld-and-metabolic-dysfunction-associated-steatohepatitis-mash.md
Podcast: [DOC Updates](https://stenobird.com/podcast/doc-updates-200053)
Published: 2026-09-03T14:00:00+00:00
Episode link: https://diabetescoreupdate.libsyn.com/special-edition-metabolic-dysfunction-associated-steatotic-liver-disease-masld-and-metabolic-dysfunction-associated-steatohepatitis-mash
Audio file: https://traffic.libsyn.com/secure/diabetescoreupdate/Special-Edition-MASLD-and-MASH.mp3?dest-id=159994
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/doc-updates-200053/episodes/special-edition-metabolic-dysfunction-associated-steatotic-liver-disease-masld-and-metabolic-dysfunction-associated-steatohepatitis-mash
Duration seconds: 1358

## Resource

What is the difference between MASH and MASLD? In this special episode, Dr. Neil Skolnik breaks down these conditions, which affect insulin resistance of the liver, an area of increasing concern for people with diabetes. This special episode is sponsored with support from Lilly . Presented by: Neil Skolnik , MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Jay Shubrook , DO, Professor and Diabetologist in the Department of Clinical Sciences and Community Health At Touro University California College of Osteopathic Medicine Susan Kuchera , MD, Program Director of the Jefferson Health Abington Family MedicineResidency Program and Associate Clinical Professor of Family and Community Medicine at the Sidney Kimmel Medical College of Thomas Jefferson University. References: Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease . Gastroenterology, 2026; 171, 164-183 Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association . Diabetes Care 2025;48(7):1057–1082 A Clinical Update on MASLD . JAMA Intern Med. 2025;185;(1):105-107. doi:10.1001/jamainternmed.2024.6431

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/doc-updates-200053/episodes/special-edition-metabolic-dysfunction-associated-steatotic-liver-disease-masld-and-metabolic-dysfunction-associated-steatohepatitis-mash/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/doc-updates-200053/special-edition-metabolic-dysfunction-associated-steatotic-liver-disease-masld-and-metabolic-dysfunction-associated-steatohepatitis-mash.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.